Healthy People 2010: Chronic kidney disease objectives
- 卷第41卷
- 印刷ISSN0272-6386
- 电子ISSN1523-6838
- 文件大小20195.70KB
- 发表时间2003
- DOI10.1016/s0272-6386(03)80005-7
The Authors ReplyDhaun, Neeraj; Bellamy, Christopher O; Cattran, Daniel C; Kluth, David C · Kidney International · 2014
Immunoglobulin A nephropathy: prognosis and managementMoran, Sarah M; Cattran, Daniel C · Nephrology Dialysis Transplantation · 2018
Response to ‘Rituximab in membranous nephropathy’Fervenza, Fernando C.; Cosio, Fernando G.; Erickson, Stephen B.; Specks, Ulrich; Herzenberg, Andrew M.; Dillon, John J.; Leung, Nelson; Cohen, Irvin M.; Wochos, Daniel N.; Bergstralh, Eric; Hladunewich, Michelle; Cattran, Daniel C. · Kidney International · 2008
Results of a controlled drug trial in membranoproliferative glomerulonephritisCattran, Daniel C; Cardella, Carl J; Roscoe, Janet M; Charron, Richard C; Rance, Phillip C; Ritchie, Susan M; Corey, Paul N · 1985
Mycophenolate mofetil and cyclosporine therapy in membranous nephropathyCattran, Daniel C · 2003
Is valsartan renoprotective in patients with IgA nephropathy?Cattran, Daniel C · Nature Clinical Practice Nephrology · 2006
Utility of renal biopsy in the clinical management of renal diseaseDhaun, Neeraj; Bellamy, Christopher O; Cattran, Daniel C; Kluth, David C · Kidney International · 2014
Utility of renal biopsy in the clinical management of renal diseaseDhaun, Neeraj; Bellamy, Christopher O; Cattran, Daniel C; Kluth, David C · Kidney International · 2014